Back to Search Start Over

Molecular Insight into Gastric Cancer Invasion—Current Status and Future Directions.

Authors :
Matsuoka, Tasuku
Yashiro, Masakazu
Source :
Cancers. Jan2024, Vol. 16 Issue 1, p54. 30p.
Publication Year :
2024

Abstract

Simple Summary: Gastric cancer (GC) is one of the most common malignancies worldwide. Owing to the absence of specific early symptoms, most patients with GC are often diagnosed at an advanced stage. Invasion is the most important feature of GC metastasis, which causes poor mortality in patients. Recently, genomic research has critically deepened our knowledge of which gene products are dysregulated in invasive and metastatic GC. This study summarizes the advances in our current understanding of the molecular mechanism of GC invasion and metastasis. We also highlight the future directions of the invasion therapeutics of GC in clinical use. Gastric cancer (GC) is one of the most common malignancies worldwide. There has been no efficient therapy for stage IV GC patients due to this disease's heterogeneity and dissemination ability. Despite the rapid advancement of molecular targeted therapies, such as HER2 and immune checkpoint inhibitors, survival of GC patients is still unsatisfactory because the understanding of the mechanism of GC progression is still incomplete. Invasion is the most important feature of GC metastasis, which causes poor mortality in patients. Recently, genomic research has critically deepened our knowledge of which gene products are dysregulated in invasive GC. Furthermore, the study of the interaction of GC cells with the tumor microenvironment has emerged as a principal subject in driving invasion and metastasis. These results are expected to provide a profound knowledge of how biological molecules are implicated in GC development. This review summarizes the advances in our current understanding of the molecular mechanism of GC invasion. We also highlight the future directions of the invasion therapeutics of GC. Compared to conventional therapy using protease or molecular inhibitors alone, multi-therapy targeting invasion plasticity may seem to be an assuring direction for the progression of novel strategies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20726694
Volume :
16
Issue :
1
Database :
Academic Search Index
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
174717497
Full Text :
https://doi.org/10.3390/cancers16010054